Home / Cancer and immune system / Exemestane
ATC L02BG06 · Endocrine Therapy
Exemestane shortage
As of 31 Oct 2026, Exemestane has a reported shortage in 3 of the 5 countries we track (Italy, Spain, Austria), covering 5 products.
Countries3/5
Products5packs or presentations
Short since7 Nov 202424 months ago
Earliest return10 Jan 2027company estimate
No return date4products
Main reasonIncreased demand
Timeline
ItalySpainAustria
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | EXEMESTANE MYLAN GENERICS | MYLAN S.P.A. | 5 Aug 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | EXEMESTANE ZENTIVA | ZENTIVA ITALIA S.R.L. | 15 Aug 2026 | not given | Increased demand Elevata richiesta |
| IT | MEXABREST | ACCORD HEALTHCARE, S.L.U. | 12 Oct 2026 | not given | Increased demand Elevata richiesta |
| ES | EXEMESTANO VIATRIS 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | Viatris Limited | 2 Sep 2026 | 10 Jan 2027 | Not stated |
| AT | Exemestan ratiopharm 25 mg Filmtabletten, 30 Stück | Teva B.V. | 7 Nov 2024 | not given | Distribution or logistics Verzögerung bei der Auslieferung |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.